UT Southwestern Medical Center scientists have discovered a protein that works with others during development to put the brakes on cell division in the heart, they report today in Nature

Using genetic engineering, researchers at UT Southwestern and Indiana University have reprogrammed scar-forming cells in mouse spinal cords to create new nerve cells, spurring recovery after spinal cord injury

UT Southwestern is one of the first in the United States to earn ACHA Adult Congenital Heart Disease (ACHD) accreditation

Scientists at UTSW have developed a technology that shuttles nanoparticles carrying gene editing and protein replacement tools to the specific tissues where they're needed

Moderately ill patients hospitalized with COVID-19 have better chances of survival if treated with therapeutic-dose anticoagulation, according to an international study involving 121 sites, including UT Southwestern Medical Center

A drug targeting a gene fusion that occurs in lung, colon, and other cancers was effective in 75 percent of patients of all ages in clinical trials, and an even higher percentage of pediatric patients, researchers at UT Southwestern's Simmons Cancer Center announced. The drug is being given fast

A team of researchers led by cardiologists at UT Southwestern Medical Center has developed a new online tool to more accurately predict who among those ages 40-65 is at the highest risk of suffering a heart attack or stroke in the next 10 years

A new research study from investigators at UT Southwestern Medical Center strongly encourages testing laboratories to periodically review their records and alert physicians when scientific knowledge evolves and genes are reclassified

Dr. Regan Allen: Annelle M. Ahmed, M.D. Women’s Health Care Award

UT Southwestern Medical Center is one of nine exclusive sites in the country enrolling multiple myeloma patients for a clinical trial of the CAR-T "living drug" therapy for cancer